文章对新型溶血栓药物及溶栓辅助药的研制进展和临床应用现状进行了综述。
Here reviewed were recent progress in research and current events of clinical application of recombinant thrombolytic agents and thrombolytic adjuvant.
由于现用溶栓药或多或少都有一些缺陷，因此人们一直都在研制开发新型的溶血栓药物。
Because most of the using thrombolytics have defect, it is necessary to develop new thrombolytics.
由于现用溶栓药或多或少都有一些缺陷，因此人们一直都在研制开发新型的溶血栓药物。
Because most of the using thrombolytics have defect, it is necessary to develop new thrombolytics.
应用推荐